Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT

Status unconfirmed

Conditions studied: Diabetic Macular Edema

In brief

Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision Home OCT The purpose of this study is to collect data on the NVHO device at up to three sites.

Key facts

Study ID

NCT05745116

Run by

Notal Vision Inc.

People needed

150

Starts

2022-11-07

Expected to finish

2023-07-31

Last updated by the study team

2023-02-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to speak, read and understand English.
• Ability to agree, understand and sign the informed consent form.
• Eighteen (18) years of age or older at the time of Informed Consent.
• Subjects diagnosed with DR (Diabetic Retinopathy) in at least one eye, with or without DME
• Best corrected Visual Acuity of 20/320 (6/96) or better in eyes participating at the study.

You may not qualify if…

• Subjects with dilated pupils.
• Subjects with other retinal disease requiring steroidal or anti-VEGF injections

Where it is running

• Elman Retina Group, PA — Baltimore, Maryland, United States (enrolling)
• The Retina Group of Washington — Fairfax, Virginia, United States (enrolling)
• Wagner Kapoor Research Institute — Norfolk, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.